Daratumumab enhances treatment efficacy in newly diagnosed multiple myeloma, showing improved MRD negativity and ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

J&J has a multi-year head start, but Gilead believes it can win market share by delivering a drug with better safety and at ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

MBD was detected using axial survey in My9 and My11, axial skeletal survey (2001–2010) and whole body computed tomography (2011 onwards) in HdB and combined skeletal survey and skeletal computed ...

It joins a number of other BCMA-directed therapies for multiple myeloma, including GSK's first-to-market antibody-drug conjugate Blenrep (belantamab mafodotin), Bristol-Myers Squibb/bluebird bio's ...

GSK continues to build the case for its multiple myeloma therapy Blenrep, which was pulled from the US market last year, with another positive phase 3 trial. The BCMA-targeted antibody-drug ...

Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE ...

Multiple myeloma (MM) is a complex and heterogeneous blood cancer, and current risk assessment tools like the Revised International Staging System (R-ISS) have limitations in accurately predicting ...

Over 150 songs have been certified diamond, and 38 artists have multiple songs on the list ... the most of any band in history. "Radioactive" earned the band's first diamond award on July 6 ...